Conditional live virus as a novel approach towards a safe live attenuated HIV vaccine (Q35193454)

7 August 2017

1 reference

title

Conditional live virus as a novel approach towards a safe live attenuated HIV vaccine (English)

1 reference

7 August 2017

1 reference

5

Ben Berkhout

0 references

Atze T Das

series ordinal

1

object named as

Atze T Das

1 reference

7 August 2017

4

Bep Klaver

1 reference

7 August 2017

3

Monique Vink

1 reference

7 August 2017

Xue Zhou

2

1 reference

7 August 2017

publication date

1 October 2002

1 reference

Expert Review of Vaccines

7 August 2017

published in

1 reference

7 August 2017

volume

1

1 reference

7 August 2017

issue

3

1 reference

7 August 2017

page(s)

293-301

1 reference

Clinical trials of HIV vaccines.

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14760584.1.3.293

Viral vectors as potential HIV-1 vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.1.3.293

Rational development of prophylactic HIV vaccines based on structural and regulatory proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.1.3.293

The basis for HIV immunotherapeutic vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.1.3.293

New hope for an AIDS vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.1.3.293

Current progress in the development of human immunodeficiency virus vaccines: research and clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.1.3.293

Importance of the nef gene for maintenance of high virus loads and for development of AIDS

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.1.3.293

Construction and in vitro properties of a series of attenuated simian immunodeficiency viruses with all accessory genes deleted

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.1.3.293

Live attenuated HIV vaccines: a proposal for further research and development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.1.3.293

Pathogenicity of live, attenuated SIV after mucosal infection of neonatal macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.1.3.293

Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.1.3.293

HIV with multiple gene deletions as a live attenuated vaccine for AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.1.3.293

Exploring the sequence space for tetracycline-dependent transcriptional activators: novel mutations yield expanded range and sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.1.3.293

In vitro evolution of a highly replicating, doxycycline-dependent HIV for applications in vaccine studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.1.3.293

A candidate live inactivatable attenuated vaccine for AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.1.3.293

Tet repressor-based system for regulated gene expression in eukaryotic cells: principles and advances

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.1.3.293

21 January 2018

Identifiers

DOI

10.1586/14760584.1.3.293

1 reference

7 August 2017

1 reference